Authors:
PATTON CL
MILLARD PS
KESSENICH CR
STORM D
KINNICUTT E
ROSEN CJ
Citation: Cl. Patton et al., SCREENING CALCANEAL ULTRASOUND AND RISK-FACTORS FOR OSTEOPOROSIS AMONG LESBIANS AND HETEROSEXUAL WOMEN, Journal of women's health, 7(7), 1998, pp. 909-915
Citation: Cr. Kessenich et al., HEALTH-RELATED QUALITY-OF-LIFE AND PARTICIPATION IN OSTEOPOROSIS CLINICAL-TRIALS, Calcified tissue international, 62(3), 1998, pp. 189-192
Citation: Cj. Rosen et Cr. Kessenich, THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - ANEVIDENCE-BASED APPROACH TO ESTROGEN REPLACEMENT THERAPY, Endocrinology and metabolism clinics of North America, 26(2), 1997, pp. 295
Citation: Cr. Kessenich et Cj. Rosen, QUALITY-OF-LIFE AND PARTICIPATION IN OSTEOPOROSIS CLINICAL-TRIALS, Journal of bone and mineral research, 12, 1997, pp. 572-572
Citation: Cj. Rosen et Cr. Kessenich, THE ROLE OF INSULIN-LIKE GROWTH-FACTOR IN SENESCENCE - CLUES FOR INTERVENTIONAL STRATEGIES IN THE ELDERLY, The Endocrinologist, 6(2), 1996, pp. 102-108
Authors:
COOK F
ROSEN CJ
VEREAULT D
STEFFENS C
KESSENICH CR
GREENSPAN S
ZIEGLER TR
WATTS NB
MOHAN S
BAYLINK DJ
Citation: F. Cook et al., MAJOR CHANGES IN THE CIRCULATORY IGF REGULATORY SYSTEM AFTER HIP FRACTURE SURGERY - POTENTIAL THERAPEUTIC IMPLICATIONS, Journal of bone and mineral research, 11, 1996, pp. 584-584
Citation: Cj. Rosen et Cr. Kessenich, COMPARATIVE CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE OF BISPHOSPHONATES IN METABOLIC BONE-DISEASES, Drugs, 51(4), 1996, pp. 537-551
Authors:
MCCLUNG MR
LOVE B
ROSEN CJ
KESSENICH CR
STOCK JL
OVERDORF J
MILLER PD
ERICKSON AL
COOK DJ
GUYATT GH
Citation: Mr. Mcclung et al., EVALUATION OF A NEW OSTEOPOROSIS QUALITY-OF-LIFE QUESTIONNAIRE (OQLQ)FOR WOMEN WITH OSTEOPOROSIS AND BACK PAIN, Journal of bone and mineral research, 10, 1995, pp. 255-255